Nuzolvence (Zoliflodacin Oral Suspension)

Nuzolvence (zoliflodacin) is a spiropyrimidinetrione bacterial type II topoisomerase inhibitor used for the treatment of uncomplicated urogenital gonorrhea due to Neisseria gonorrhoeae in adults and pediatric patients 12 years of age and older, weighing at least 35 kg.

Usage to Reduce Development of Drug-Resistant Bacteria: To reduce the development of drug-resistant bacteria and maintain the effectiveness of Nuzolvence and other antibacterial drugs, Nuzolvence should be used only for the treatment or prevention of infections that are proven or strongly suspected to be caused by bacteria.

Recommended Dosage
The recommended dose in adults and pediatric patients aged 12 years and older weighing at least 35 kg is 3 grams (g) (one packet) administered as a single dose orally. Take this medicine on an empty stomach, 1 hour before or 2 hours after food.

This therapeutic drug must be mixed with water before administering. It is not advisable to mix Nuzolvence with other liquids or sprinkle on food. Do not take it in the dry form. Administer the entire dose within 15 minutes of mixing. If the dose is not administered within 15 minutes of mixing, a new dose must be prepared.

• Certain animal findings suggest that this medicine may cause harm to an unborn baby. Pregnant females should avoid using this drug unless clearly required. Appropriate contraception is required during treatment. In case of pregnancy, discontinue treatment promptly and consult a clinician immediately for risk assessment and guidance.
• The medicine may affect sperm count and pose risk to an unborn child through exposure. Males with female partners of reproductive potential should use effective contraception during treatment and for a period after stopping treatment, as advised by healthcare professionals.
• Testicular toxicity has been observed in nonclinical studies, indicating possible effects on male fertility. This medicine may reduce sperm production or function. Males concerned about future fertility should discuss sperm preservation options with a healthcare professional before starting treatment initiation.
• Serious hypersensitivity reactions, including itching, rash, swelling, or breathing difficulty, may occur. Discontinue treatment immediately in case allergic symptoms occur. Seek urgent medical attention. It is not advisable to restart therapy in case a severe allergic reaction is confirmed by a doctor after evaluation.
• Use of this treatment may alter normal gut bacteria and causes Clostridioides difficile infection. Symptoms include persistent abdominal pain, diarrhea, and fever. Assess patients with diarrhea promptly and discontinue treatment if infection is suspected or confirmed by testing appropriately.
• Inappropriate or prolonged use of this treatment may promote development of drug-resistant bacteria. Use only for approved indications and prescribed duration. Skipping doses or stopping treatment course early can reduce effectiveness and increase resistance risk, limiting future treatment options for patients globally.

What documents are required to import NUZOLVENCE to India?

NUZOLVENCE (zoliflodacin) oral suspension can be imported by patients or government hospitals in the name of the patients only.
The following documentation is required to import the product:

• A valid prescription from a qualified doctor.
• Patients diagnostic reports
• Patient ID proof (issued by the government of India)

How does the order get confirmed?

The order will be confirmed only after the receipt of:

• A valid prescription from the Doctor
• Import permit if applicable

Is NUZOLVENCE available in India?

NUZOLVENCE (zoliflodacin oral suspension) is a (prescription drug, prescription medication, or prescription medicine) pharmaceutical drug that legally requires a medical prescription to be dispensed.

IPN (Indian Pharma Network) helps import cancer medicines on the named patient supply (NPS). Indian Pharma Network is the facilitator, providing input

• On the availability of Nuzolvence in India (Mumbai, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore, Pune, etc.)
• On availability in Gulf countries (Bahrain, Oman, Qatar, Kuwait, Iraq, Saudi Arabia, and the UAE).
• Nuzolvence price in India.
• Finding Genuine and reliable sources from the USA, Canada, Europe, and Australia
• Ensuring 100% transparency.

NUZOLVENCE can be made available to patients, doctors, and hospitals in Mumbai, Goa, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore, Srinagar, Jammu, Jaipur, Chandigarh, Ludhiana, Noida, Gurgaon, Lucknow, and Pune, and other cities in India. The order will be confirmed only after the receipt of a valid prescription from the doctor and an import permit.

IPN (Indian Pharma Network) can facilitate the supply of NUZOLVENCE (prescription medicines) to all locations in the world and India after fulfilling the legal requirements (if applicable).

Please contact +91 98104 69557 | Toll-Free Number: 1800-889-1064 or write us at info@indianpharmanetwork.in for Nuzolvence cost in India.

We guarantee quality and delivery anywhere in the world as per the buyer’s requirements.

Indian Pharma Network can source NUZOLVENCE (Cancer Treatment Medicines) from across the globe and can supply. Indian Pharma offers its customers worldwide access to the best available treatment.

Indian Pharma Network (IPN) can dispense any valid prescription in the shortest possible time. All prescriptions are dispensed and checked by registered pharmacists and dispatched to the Patient’s address only from New Delhi, India.

What is the Generic Name for the trade name drug Nuzolvence®?

Zoliflodacin is the Generic Name for the trade name drug Nuzolvence®.

What is the Manufacturer’s Name of Nuzolvence®?

Nuzolvence® is manufactured by Innoviva Specialty Therapeutics, Inc.

Is Nuzolvence approved by the FDA?

Yes. Nuzolvence is approved by the FDA. date of first approval: December 12, 2025.

What is the dosage and form of Nuzolvence® supplied?

Nuzolvence is supplied for oral suspension: 3 g of zoliflodacin in each unit-dose packet of Nuzolvence®.

What are the most common side effects of Nuzolvence® 3 g oral suspension?

The most commonly reported side effects of Nuzolvence® are nausea, neutropenia, headache, leukopenia, dizziness, and diarrhea.

How does Nuzolvence Import in India work?

Nuzolvence Import in India is possible through the Named Patient Program. This means the medicine can be imported for a specific patient with a valid doctor’s prescription. Indian Pharma Network helps manage the complete process, including approvals and delivery, making sure the medicine reaches the patient safely and legally.

How much does Nuzolvence® 3 g oral suspension cost in India?

Nuzolvence® is not yet approved in India. However, patients in India can legally access it through the provision called the Named Patient Program (NPP). Nuzolvence prices may fluctuate over time because of market dynamics and regulatory changes. For the most transparent and latest Nuzolvence cost in India, please call/WhatsApp +91 98104 69557 or send an email to info@indianpharmanetwork.in.

Can Nuzolvence® 3 g oral suspension be available in SAARC countries?

Apart from Gulf countries, Nuzolvence® 3 g oral suspension can be accessed through import provisions like the Named Patient Program (NPP) in SAARC countries (India, Afghanistan, Maldives, Nepal, Bangladesh, Bhutan, Pakistan, and Sri Lanka). Indian Pharma Network (IPN) can help facilitate the legal supply of Nuzolvence® oral suspension in these countries. We help provide legal access to this therapeutic drug through our reliable channels.

Is it safe to buy Nuzolvence® 3 g Oral Suspension online in India?

Yes, one can buy Nuzolvence in India at the lowest price from the Indian Pharma Network (IPN) if this medicinal product is not yet registered or available in their country. We can help facilitate the supply of Nuzolvence® oral suspension through legal channels.

What are the storage conditions of Nuzolvence® 3 g oral suspension?

Stored in the original packaging at room temperature 20 °C to 25 °C (68 °F to 77 °F); excursions permitted to 15 °C to 30 °C (59 °F to 86 °F). Do not freeze.